These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 10353604)

  • 1. Characterization of a naturally occurring ErbB4 isoform that does not bind or activate phosphatidyl inositol 3-kinase.
    Elenius K; Choi CJ; Paul S; Santiestevan E; Nishi E; Klagsbrun M
    Oncogene; 1999 Apr; 18(16):2607-15. PubMed ID: 10353604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A natural ErbB4 isoform that does not activate phosphoinositide 3-kinase mediates proliferation but not survival or chemotaxis.
    Kainulainen V; Sundvall M; Määttä JA; Santiestevan E; Klagsbrun M; Elenius K
    J Biol Chem; 2000 Mar; 275(12):8641-9. PubMed ID: 10722704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A naturally occurring secreted human ErbB3 receptor isoform inhibits heregulin-stimulated activation of ErbB2, ErbB3, and ErbB4.
    Lee H; Akita RW; Sliwkowski MX; Maihle NJ
    Cancer Res; 2001 Jun; 61(11):4467-73. PubMed ID: 11389077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential nuclear localization and kinase activity of alternative ErbB4 intracellular domains.
    Sundvall M; Peri L; Määttä JA; Tvorogov D; Paatero I; Savisalo M; Silvennoinen O; Yarden Y; Elenius K
    Oncogene; 2007 Oct; 26(48):6905-14. PubMed ID: 17486069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ErbB kinases and NDF signaling in human prostate cancer cells.
    Grasso AW; Wen D; Miller CM; Rhim JS; Pretlow TG; Kung HJ
    Oncogene; 1997 Nov; 15(22):2705-16. PubMed ID: 9400997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of EGFR-mediated phosphoinositide-3-OH kinase (PI3-K) signaling and glioblastoma phenotype by signal-regulatory proteins (SIRPs).
    Wu CJ; Chen Z; Ullrich A; Greene MI; O'Rourke DM
    Oncogene; 2000 Aug; 19(35):3999-4010. PubMed ID: 10962556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression, localization, and regulation of the neuregulin receptor ErbB3 in mouse heart.
    Campreciós G; Lorita J; Pardina E; Peinado-Onsurbe J; Soley M; Ramírez I
    J Cell Physiol; 2011 Feb; 226(2):450-5. PubMed ID: 20672328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand-independent regulation of ErbB4 receptor phosphorylation by activated Ras.
    Tal-Or P; Erlich S; Porat-Shliom N; Goldshmit Y; Ben-Baruch G; Shaharabani E; Kloog Y; Pinkas-Kramarski R
    J Cell Biochem; 2006 Aug; 98(6):1482-94. PubMed ID: 16518842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel epidermal growth factor-like molecule containing two follistatin modules stimulates tyrosine phosphorylation of erbB-4 in MKN28 gastric cancer cells.
    Uchida T; Wada K; Akamatsu T; Yonezawa M; Noguchi H; Mizoguchi A; Kasuga M; Sakamoto C
    Biochem Biophys Res Commun; 1999 Dec; 266(2):593-602. PubMed ID: 10600548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of ERBB4 JM-a CYT-1 and CYT-2 isoforms in transgenic mice reveals isoform-specific roles in mammary gland development and carcinogenesis.
    Wali VB; Gilmore-Hebert M; Mamillapalli R; Haskins JW; Kurppa KJ; Elenius K; Booth CJ; Stern DF
    Breast Cancer Res; 2014 Dec; 16(6):501. PubMed ID: 25516216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases.
    Carraway KL; Weber JL; Unger MJ; Ledesma J; Yu N; Gassmann M; Lai C
    Nature; 1997 May; 387(6632):512-6. PubMed ID: 9168115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of phosphatidylinositol 3-kinase is necessary for differentiation of FDC-P1 cells following stimulation of type III receptor tyrosine kinases.
    Kubota Y; Angelotti T; Niederfellner G; Herbst R; Ullrich A
    Cell Growth Differ; 1998 Mar; 9(3):247-56. PubMed ID: 9543391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cbl and Itch binding sites in ERBB4 CYT-1 and CYT-2 mediate K48- and K63-polyubiquitination, respectively.
    Meijer IM; van Rotterdam W; van Zoelen EJ; van Leeuwen JE
    Cell Signal; 2013 Feb; 25(2):470-8. PubMed ID: 23153581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-binding EGF-like growth factor expression increases selectively in bladder smooth muscle in response to lower urinary tract obstruction.
    Borer JG; Park JM; Atala A; Nguyen HT; Adam RM; Retik AB; Freeman MR
    Lab Invest; 1999 Nov; 79(11):1335-45. PubMed ID: 10576204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYT-1 isoform of ErbB4 is an independent prognostic factor in serous ovarian cancer and selectively promotes ovarian cancer cell growth in vitro.
    Paatero I; Lassus H; Junttila TT; Kaskinen M; Bützow R; Elenius K
    Gynecol Oncol; 2013 Apr; 129(1):179-87. PubMed ID: 23313737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phe45 of NRG2beta is critical for the affinity of NRG2beta for ErbB4 and for potent stimulation of ErbB4 signaling by NRG2beta*.
    Hobbs SS; Gallo RM; Riese DJ
    Growth Factors; 2005 Dec; 23(4):273-83. PubMed ID: 16338790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NDF/heregulin-induced cell cycle changes and apoptosis in breast tumour cells: role of PI3 kinase and p38 MAP kinase pathways.
    Daly JM; Olayioye MA; Wong AM; Neve R; Lane HA; Maurer FG; Hynes NE
    Oncogene; 1999 Jun; 18(23):3440-51. PubMed ID: 10376522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five carboxyl-terminal residues of neuregulin2 are critical for stimulation of signaling by the ErbB4 receptor tyrosine kinase.
    Hobbs SS; Cameron EM; Hammer RP; Le AT; Gallo RM; Blommel EN; Coffing SL; Chang H; Riese DJ
    Oncogene; 2004 Jan; 23(4):883-93. PubMed ID: 14661053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD28-dependent killing by human YT cells requires phosphatidylinositol 3-kinase activation.
    Lu Y; Rodriguez R; Bjorndahl J; Phillips CA; Trevillyan JM
    Eur J Immunol; 1996 Jun; 26(6):1278-84. PubMed ID: 8647205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A; Arai K
    Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.